<DOC>
	<DOCNO>NCT00581698</DOCNO>
	<brief_summary>The purpose study determine whether consistently identify first lymph node ( `` sentinel node '' ) drain melanoma .</brief_summary>
	<brief_title>Intraoperative Mapping Regional Lymphatics Draining Primary Site Melanoma Using Isosulfan Blue</brief_title>
	<detailed_description>The issue elective lymph node dissection ( LND ) management melanoma patient clinically negative node remain controversial . The concept elective LND attractive provide opportunity detect remove occult micrometastases become clinically apparent . Numerous retrospective analysis consistently show 15-20 % long term survival advantage patient undergo elective LND find positive node , compare undergoing therapeutic LND clinically positive node . The majority patient undergo elective LND however , lymph node involvement , impact removal negative node survival patient unknown . The substantial morbidity procedure lead conduct number important prospective randomize trial design define impact elective LND survival patient clinically node negative melanoma . In 1982 , World Health Organization report end result 553 The primary objective protocol establish feasibility lymph node mapping , use preoperative lymphoscintigraphy intraoperative blue dye injection detect sentinel node patient risk regional lymph node metastasis primary melanoma .</detailed_description>
	<mesh_term>Melanoma</mesh_term>
	<criteria>primary melanoma Clark III Breslow thickness &gt; 1 mm , Clark IVV Breslow thickness clinically negative regional node previous definitive wide local excision primary melanoma skin graft inflammatory lesion area primary melanoma likely drain nodal basin pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Melanoma</keyword>
	<keyword>Negative regional lymph node</keyword>
	<keyword>Primary melanoma Clark III Breslow thickness &gt; 1 mm , Clark</keyword>
	<keyword>IV-V Breslow thickness , clinically negative regional node</keyword>
</DOC>